[go: up one dir, main page]

MX2018008146A - Activacion de plaquetas controlada por calcio mediante estimulacion electrica. - Google Patents

Activacion de plaquetas controlada por calcio mediante estimulacion electrica.

Info

Publication number
MX2018008146A
MX2018008146A MX2018008146A MX2018008146A MX2018008146A MX 2018008146 A MX2018008146 A MX 2018008146A MX 2018008146 A MX2018008146 A MX 2018008146A MX 2018008146 A MX2018008146 A MX 2018008146A MX 2018008146 A MX2018008146 A MX 2018008146A
Authority
MX
Mexico
Prior art keywords
electrical stimulation
via electrical
controlled activation
platelets via
present
Prior art date
Application number
MX2018008146A
Other languages
English (en)
Other versions
MX392919B (es
Inventor
Bogdan Neculaes Vasile
Soliz Torres Andrew
Lambert KLOPMAN Steve
Original Assignee
Gen Electric
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Electric filed Critical Gen Electric
Publication of MX2018008146A publication Critical patent/MX2018008146A/es
Publication of MX392919B publication Critical patent/MX392919B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0644—Platelets; Megakaryocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)

Abstract

La presente descripcion se relaciona con la generacion de un producto de plaquetas activado en el cual uno o mas de la presencia o ausencia de coagulos, el tiempo de formacion de coagulo (si esta presente) y/o la fuerza mecanica de los coagulos (si esta presente) están controlados por la presencia o concentracion de iones de calcio durante el proceso 5 de activacion; en ciertas modalidades, la concentracion de iones de calcio se controla en la presencia de campos electricos pulsados o un activador quimico (por ejemplo, trombina) como parte del proceso de activacion.
MX2018008146A 2015-12-30 2016-12-29 Activacion de plaquetas controlada por calcio mediante estimulacion electrica MX392919B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/984,988 US10633645B2 (en) 2015-12-30 2015-12-30 Calcium controlled activation of platelets via electrical stimulation
PCT/US2016/069197 WO2017117385A2 (en) 2015-12-30 2016-12-29 Calcium controlled activation of platelets via electrical stimulation

Publications (2)

Publication Number Publication Date
MX2018008146A true MX2018008146A (es) 2018-12-06
MX392919B MX392919B (es) 2025-03-24

Family

ID=57868356

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018008146A MX392919B (es) 2015-12-30 2016-12-29 Activacion de plaquetas controlada por calcio mediante estimulacion electrica

Country Status (10)

Country Link
US (2) US10633645B2 (es)
EP (2) EP3738604B1 (es)
JP (1) JP7050680B2 (es)
KR (1) KR102722475B1 (es)
CN (2) CN108697763B (es)
AU (1) AU2016380342B2 (es)
BR (1) BR112018013444A2 (es)
MX (1) MX392919B (es)
RU (1) RU2742937C2 (es)
WO (1) WO2017117385A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10968423B2 (en) 2018-02-26 2021-04-06 General Electric Company System and method for electric pulse based activation of biological samples
KR102104871B1 (ko) * 2020-01-02 2020-04-27 주식회사 엠엔 펄스 미세 전자기장 방식의 키성장 보조장치 및 그 장치의 구동방법
TW202527970A (zh) * 2024-01-05 2025-07-16 艾瑞生醫股份有限公司 以人類血小板製備外泌體的方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3180824B2 (ja) * 1991-08-30 2001-06-25 シスメックス株式会社 血液凝固試薬
US5293772A (en) * 1992-01-17 1994-03-15 Center For Innovative Technology Instrumentation and method for evaluating platelet performance during clotting and dissolution of blood clots and for evaluating erythrocyte flexibility
US6322785B1 (en) 1999-03-02 2001-11-27 Natrex Technologies Methods and compositions for bone graft implants
US6326711B1 (en) 1999-09-07 2001-12-04 Tokyo Parts Industrial Co., Ltd. DC brushless motor having eccentric rotor
EP1504269B1 (en) * 2002-05-01 2007-07-25 Synapse B.V. Diagnostic test for determining the concentration of transient proteolytic activity in composite biological media
US7565201B2 (en) 2004-12-17 2009-07-21 Eastern Virginia Medical School Activation of calcium-mediated cell functions in cells and tissues, including aggregation of human platelets. by nanosecond pulsed electric fields
CA2602613A1 (en) * 2005-04-04 2006-10-19 The Regents Of The University Of California Inorganic materials for hemostatic modulation and therapeutic wound healing
EP1717588A1 (en) * 2005-04-29 2006-11-02 Synapse B.V. Measuring thrombin activity in whole blood
US7837941B2 (en) * 2006-04-07 2010-11-23 Agamatrix, Inc. Method and apparatus for monitoring alteration of flow characteristics in a liquid sample
US8034014B2 (en) 2007-03-06 2011-10-11 Biomet Biologics, Llc Angiogenesis initation and growth
WO2010042658A1 (en) 2008-10-07 2010-04-15 Bioparadox, Llc Use of platelet rich plasma composition in the treatment of cardiac conduction abnormalities
US20110318319A1 (en) 2008-11-13 2011-12-29 Old Dominion University ACTIVATION and AGGREGATION OF HUMAN PLATELETS AND FORMATION OF PLATELET GELS BY NANOSECOND PULSED ELECTRIC FIELDS
KR101114712B1 (ko) * 2009-10-23 2012-02-29 세원셀론텍(주) 염화칼슘용액과 제1형 콜라겐으로 혈소판풍부혈장(ｐｒｐ)을 활성화하여 조직재생을 유도하는 조성물의 제조방법
ES2402144T3 (es) * 2010-05-25 2013-04-29 Gwowei Technology Co., Ltd. Lisado plaquetario inactivado que contiene factores de crecimiento empobrecido en PDGF y VEGF y su procedimiento de preparación
US9314609B2 (en) 2011-10-28 2016-04-19 Martin Brown Device for providing electrical stimulation of a human knee
CN103110947A (zh) * 2011-11-16 2013-05-22 玛旺干细胞医学生物科技股份有限公司 用以活化血小板的添加剂
EP2976097B1 (en) * 2013-03-21 2021-05-26 CollPlant Ltd. Compositions comprising collagen and prp for tissue regeneration and their production method
US9078862B2 (en) 2013-06-06 2015-07-14 General Electric Company Platelet activation using long electric field pulses
US9238808B2 (en) 2013-06-06 2016-01-19 General Electric Company Modular adjustable pulse generator
US9452199B2 (en) 2014-01-17 2016-09-27 General Electric Company Platelet activation and growth factor release using electric pulses
US9708597B2 (en) 2014-01-17 2017-07-18 General Electric Company Electric pulse generation systems using capacitive coupling
US11285100B2 (en) 2014-02-20 2022-03-29 Ortho Regenerative Technologies Inc. Freeze-dried polymer compositions for mixing with platelet rich plasma to form implants for tissue repair and/or compositions for therapeutic intra-articular injections
US20170045494A1 (en) 2014-04-28 2017-02-16 T2 Biosystems, Inc. Systems and methods for identifying coagulopathies
US9752120B2 (en) 2015-03-31 2017-09-05 General Electric Company Activated platelet composition with tunable growth factor level

Also Published As

Publication number Publication date
CA3009523A1 (en) 2017-07-06
RU2742937C2 (ru) 2021-02-11
EP3738604A2 (en) 2020-11-18
EP3397268B1 (en) 2020-07-08
JP2019501911A (ja) 2019-01-24
CN108697763B (zh) 2022-12-09
CN108697763A (zh) 2018-10-23
US20170191052A1 (en) 2017-07-06
WO2017117385A3 (en) 2017-08-10
KR20180098402A (ko) 2018-09-03
AU2016380342A1 (en) 2018-07-12
US10633645B2 (en) 2020-04-28
BR112018013444A2 (pt) 2019-02-12
RU2018121952A3 (es) 2020-04-08
AU2016380342B2 (en) 2023-04-13
EP3738604B1 (en) 2023-09-13
WO2017117385A2 (en) 2017-07-06
KR102722475B1 (ko) 2024-10-25
RU2018121952A (ru) 2020-01-30
JP7050680B2 (ja) 2022-04-08
EP3738604A3 (en) 2021-01-13
US20200239868A1 (en) 2020-07-30
MX392919B (es) 2025-03-24
EP3397268A2 (en) 2018-11-07
CN115873793A (zh) 2023-03-31
US11591590B2 (en) 2023-02-28

Similar Documents

Publication Publication Date Title
MX2017010252A (es) Mejoras de algoritmos en un sistema haptico.
MX385292B (es) Métodos y dispositivo de generación de gas de peróxido de hidrógeno purificado.
CL2018003565A1 (es) Anticuerpos antifactor de la coagulación xi.
MX2018008146A (es) Activacion de plaquetas controlada por calcio mediante estimulacion electrica.
BR112017001049A2 (pt) material biocomposto anisotrópico, implantes médicos contendo o mesmo e métodos de tratamento do mesmo
UY36720A (es) Uso del carbonato de calcio tratado mediante reacción superficial como agente anti bloqueador
NI201700071A (es) Anticuerpos anti-cd38 para el tratamiento de la leucemia mieloide aguda
MX377166B (es) Activacion de las plaquetas y liberacion del factor de crecimiento utilizando pulsos electricos.
MX378572B (es) Anticuerpos anti-factor de la coagulacion xi.
CR20180529A (es) Anticuerpos anti-factor bb del complemento y usos de estos referencia cruzada
MX2015010134A (es) Aparato medico, sistema y metodo.
WO2018195177A8 (en) Device and method for treating osteonecrosis
PL3259258T3 (pl) Sposób epoksydacji olefiny nadtlenkiem wodoru
CY1121242T1 (el) Μεθοδος για την επεξεργασια λαχανικων
MX2016002874A (es) Aparato medico y metodo.
MX2017005522A (es) Tratamiento novedoso de la cornea usando laminina.
BR112017014098A2 (pt) métodos de isolamento de plaquetas
FI20135683A7 (fi) Saostettua kalsiumkarbonaattia sisältävä koostumus, menetelmä sen valmistamiseksi sekä sen käytöt
MX2018010310A (es) Sistemas y metodos para controlar una planta de energia.
TW201614293A (en) Micro-perforated hole reflectors in light guide plates
MX379472B (es) Molécula terapéutica antiplaquetaria y anticoagulante que comprende heparina conjugada a una proteína de plasma.
TN2018000161A1 (en) Hydrogen peroxide aqueous solution containing a specific stabilizer
MX374865B (es) Solución de diálisis.
AR114829A1 (es) Artículo moldeado de adsorción de litio y método de fabricación del mismo
MX2018004656A (es) Baclofeno intravenoso y metodos de tratamiento.